Back to Search Start Over

Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody

Authors :
Mittler, Eva
Serris, Alexandra
Esterman, Emma
Florez, Catalina
Polanco, Laura
O’brien, Cecilia
Slough, Megan
Tynell, Janne
Gröning, Remigius
Sun, Yan
Abelson, Dafna
Wec, Anna
Haslwanter, Denise
Keller, Markus
Ye, Chunyan
Bakken, Russel
Jangra, Rohit
Dye, John
Ahlm, Clas
Rappazzo, C. Garrett
Ulrich, Rainer
Zeitlin, Larry
Geoghegan, James
Bradfute, Steven
Sidoli, Simone
Forsell, Mattias N.E.
Strandin, Tomas
Rey, Felix
Herbert, Andrew
Walker, Laura
Chandran, Kartik
Guardado-Calvo, Pablo
Albert Einstein College of Medicine [New York]
Virologie Structurale - Structural Virology
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Adimab [Lebanon]
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
Umeå University
Mapp Biopharmaceutical Inc.
Friedrich-Loeffler-Institut (FLI)
The University of New Mexico [Albuquerque]
Haaga-Helia University of Applied Sciences [Helsinki, Finland]
This research was supported by NIAID of the NIH under award number U19AI142777 (Centers of Excellence in Translational Research) to K.C., L.M.W., J.M.D., A.S.H., S.B.B., M.N.E.F., and L.Z. M.N.E.F. was supported by a grant from the Swedish Research Council (no. 2020-06235). C.A. was supported by research grants from Region Västerbotten and Umeå University (RV-579011, RV-734361, and RV-965866). J.T. was supported by the Finnish Cultural Foundation (no. 00221066). R.K.J. was supported by grants from the NIH (R2AI156482, P20GM134974, and P20GM121307). R.G.U. was supported by the Bundesministerium für Bildung und Forschung (BMBF) within the Research Network Zoonotic Infectious Diseases (01KI1721A and 01KI2004A). T.S. was supported by the Academy of Finland (no. 321809). P.G.-C. was supported by a grant by the National French Research Agency (ANR-18-CE11-0011), and A.S. was supported with a fellowship by the French Fondation pour la Recherche Médicale (FDM20170638040). F.A.R. and P.G.-C. were supported by Labex IBEID (ANR-10-LABX-62-IBEID).
ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010)
ANR-18-CE11-0011,LISEFU,Base structurale de la détection des lipides dans la fusion virale(2018)
Source :
Science Translational Medicine, Science Translational Medicine, 2023, 15 (700), pp.eadg1855. ⟨10.1126/scitranslmed.adg1855⟩
Publication Year :
2023
Publisher :
HAL CCSD, 2023.

Abstract

International audience; Emerging rodent-borne hantaviruses cause severe diseases in humans with no approved vaccines or therapeutics. We recently isolated a monoclonal broadly neutralizing antibody (nAb) from a Puumala virus-experienced human donor. Here, we report its structure bound to its target, the Gn/Gc glycoprotein heterodimer comprising the viral fusion complex. The structure explains the broad activity of the nAb: It recognizes conserved Gc fusion loop sequences and the main chain of variable Gn sequences, thereby straddling the Gn/Gc heterodimer and locking it in its prefusion conformation. We show that the nAb's accelerated dissociation from the divergent Andes virus Gn/Gc at endosomal acidic pH limits its potency against this highly lethal virus and correct this liability by engineering an optimized variant that sets a benchmark as a candidate pan-hantavirus therapeutic.

Subjects

Subjects :
[SDV]Life Sciences [q-bio]

Details

Language :
English
ISSN :
19466234 and 19466242
Database :
OpenAIRE
Journal :
Science Translational Medicine, Science Translational Medicine, 2023, 15 (700), pp.eadg1855. ⟨10.1126/scitranslmed.adg1855⟩
Accession number :
edsair.od......2100..83c98787290c012fd09aa9071146b663
Full Text :
https://doi.org/10.1126/scitranslmed.adg1855⟩